These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22809205)

  • 1. Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.
    Patel S
    Expert Rev Proteomics; 2012 Jun; 9(3):249-65. PubMed ID: 22809205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic technologies for biomarker studies in psychiatry: advances and needs.
    Martins-de-Souza D; Guest PC; Vanattou-Saifoudine N; Harris LW; Bahn S
    Int Rev Neurobiol; 2011; 101():65-94. PubMed ID: 22050849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics for investigating psychiatric disorders.
    Filiou MD; Turck CW; Martins-de-Souza D
    Proteomics Clin Appl; 2011 Feb; 5(1-2):38-49. PubMed ID: 21280236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic research in psychiatry.
    Taurines R; Dudley E; Grassl J; Warnke A; Gerlach M; Coogan AN; Thome J
    J Psychopharmacol; 2011 Feb; 25(2):151-96. PubMed ID: 20142298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics--a blessing or a curse? Application of proteomics technology to transplant medicine.
    Kienzl-Wagner K; Pratschke J; Brandacher G
    Transplantation; 2011 Sep; 92(5):499-509. PubMed ID: 21716169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker discovery in psychiatric disorders.
    Schwarz E; Bahn S
    Electrophoresis; 2008 Jul; 29(13):2884-90. PubMed ID: 18512679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of proteomics in biomarker discovery: prognosis and diagnosis of neuropsychiatric disorders.
    Patel S
    Adv Protein Chem Struct Biol; 2014; 94():39-75. PubMed ID: 24629185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching for reliable premortem protein biomarkers for prion diseases: progress and challenges to date.
    Ma D; Li L
    Expert Rev Proteomics; 2012 Jun; 9(3):267-80. PubMed ID: 22809206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
    deVera IE; Katz JE; Agus DB
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics technologies for biomarker discovery in multiple sclerosis.
    Singh V; Hintzen RQ; Luider TM; Stoop MP
    J Neuroimmunol; 2012 Jul; 248(1-2):40-7. PubMed ID: 22129845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Present possibilities and future development of clinical proteomics].
    Lehmann S; Dupuy A; Peoc'h K; Roche S; Baudin B; Quillard M; Berger F; Briand G; Chwetzoff S; Dine G; Gonzalo P; Dastugue B; Sève M; Siest G; Beaudeux JL
    Ann Biol Clin (Paris); 2007; 65(5):463-71. PubMed ID: 17913666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-enabled biomarker discovery and detection.
    Rakowska PD; Ryadnov MG
    Biomark Med; 2011 Jun; 5(3):387-96. PubMed ID: 21657848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic biomarkers for psychiatric disorders: a progress update.
    Martins-de-Souza D; Turck CW
    Biomark Med; 2012 Apr; 6(2):189-92. PubMed ID: 22448792
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychiatric research: psychoproteomics, degradomics and systems biology.
    Kobeissy FH; Sadasivan S; Liu J; Gold MS; Wang KK
    Expert Rev Proteomics; 2008 Apr; 5(2):293-314. PubMed ID: 18466058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics in South Africa: current status, challenges and prospects.
    Ndimba BK; Thomas LA
    Biotechnol J; 2008 Nov; 3(11):1368-74. PubMed ID: 19016510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.
    Ray S; Reddy PJ; Jain R; Gollapalli K; Moiyadi A; Srivastava S
    Proteomics; 2011 Jun; 11(11):2139-61. PubMed ID: 21548090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical considerations for mass spectrometry profiling in serum biomarker discovery.
    Whiteley GR; Colantonio S; Sacconi A; Saul RG
    Clin Lab Med; 2009 Mar; 29(1):57-69. PubMed ID: 19389551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.